Buy, Hold, or Sell: Everyone Misreads Amazon's Bet
Amazon faces a cash-heavy growth cycle as cloud demand and custom chips drive revenue. The market clamps down on near...
When To Convert 401k To A Retirement Plan
Converting a 401k to a retirement plan can be a strategic move. Learn when it's the right time to make that transition.
20,599 articles
Haverty (HVT) 2025 Earnings: A Comprehensive Investor Look
As Haverty prepares for its 2025 earnings release, investors seek clarity on margins, store performance, and forward ...
Figma Stock Shot February: What Investors Should Know
In February, Figma exhibited a notable stock move as investor interest focused on cloud-based collaboration tools. Th...
MasTec (MTZ) Up 150% Year, Analyst Sees More Upside
mastec (mtz) 150% year momentum drives the rally as the company backs a strong 2026 outlook. Analysts see upside as b...
Planet Labs Jumps After Hours as Backlog Surges Past $900M
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
Unity 2026 Earnings Call: Key Takeaways and Outlook
This in-depth look breaks down Unity's Q1 2026 earnings call, outlining revenue drivers, profitability, and what the ...
Howmet (HWM) 2026 Earnings: Key Trends and Outlook
A practical, down-to-earth look at Howmet’s 2026 earnings outlook. This guide breaks down drivers, risks, and actiona...
Cerebras Systems' Chips Faster: Two Nvidia Edges in AI Invest
Investors are eyeing Cerebras Systems' chips faster claims against Nvidia's Blackwell models. This deep dive explains...
SpaceX Rocket Lab: Which Space Stock Has Room to Run
Investors often ask spacex rocket lab: which has more upside. This in-depth guide compares the private powerhouse Spa...
Google Just Give Investors 30B Reasons for SpaceX IPO
A hypothetical SpaceX IPO could ride a powerful tailwind if a Google cloud deal brings $30 billion in AI compute reve...
This Stock Will Dominate the Second Half of 2026 Markets
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status